Overview
Clinical Benefits
- Skin rejuvenation
- Anti-aging complexion
- Reduced redness / inflammation
- Light systemic repair
Administration
Subcutaneous injection (SubQ)
Drug class: repair blend
Vendor-Verified Recipe
70 mg vial + 2 mL BAC → 35 mg/mL
Vial size
70 mg
BAC water
2 mL
Concentration
35 mg/mL
Vial capacity
3 mL
A 3.5 mg dose draws 10 units on a U-100 insulin syringe.
70 mg proprietary blend (GHK-Cu + BPC-157 + TB-500) in a 3 mL vial. 2 mL BAC water is the vendor spec — never 3 mL, never 4 mL.
This is the vendor's tested-in-practice recipe for GLOW70. LIA quotes these numbers verbatim; any BAC volume that exceeds the vial capacity or the solubility ceiling is physically impossible and will be rejected.
Clinical Dosing
Typical dosage
3.5mg total blend, 3-5x per week SubQ
Starting dose
3.5mg total blend per injection
Cadence
3-5x weekly
Full titration schedule
| Phase | Dose |
|---|---|
| Weeks 1-2 | 1.5mg total blend |
| Weeks 3-4 | 2.5mg total blend |
| Week 5+ | 3.5mg total blend |
Safety Profile
Side effects
- • Mild injection-site irritation
- • Possible flushing from GHK-Cu copper load
Contraindications
- • Active malignancy (BPC component caution)
- • Wilson's disease (GHK-Cu copper load)
- • Pregnancy / nursing (insufficient data)
Frequently asked questions
GLOW70 is most commonly researched for: Skin rejuvenation, Anti-aging complexion, Reduced redness / inflammation, Light systemic repair.
Ready to build a protocol with GLOW70?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.